Italia markets closed
FTSE MIB
33.812,44 +41,37 (+0,12%) Dow Jones
40.589,34 +654,27 (+1,64%) Nasdaq
17.357,88 +176,16 (+1,03%) Nikkei 225
37.667,41 -202,10 (-0,53%) Petrolio
76,44 -1,84 (-2,35%) Bitcoin EUR
62.555,89 +825,96 (+1,34%)
Genprex, Inc. (0A8I.L)
LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 05:30PM BST
| Chiusura precedente | 1,8850 |
| Aperto | 1,9005 |
| Denaro | 0,0000 x N/D |
| Domanda | 0,0000 x N/D |
| Min-Max giorno | 1,9005 - 1,9005 |
| Intervallo di 52 settimane | 0,1903 - 7,9900 |
| Volume | |
| Media Volume | 2.261 |
| Capitalizzazione | N/D |
| Beta (mensile su 5 anni) | -0,51 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,3950 |
| Prossima data utili | 21 ago 2024 - 26 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation,” please visit: https://nnw.fm/619wq More than 30 million pe
© 2024 Yahoo. Tutti i diritti riservati.